spacer
home > ebr > summer 2003 > england - europe's low risk biotech location
PUBLICATIONS
European Biopharmaceutical Review

England - Europe's Low Risk Biotech Location

Scientists worldwide are celebrating the 50th anniversary of the deciphering of the structure of DNA. But in Cambridge there is special cause for celebration, for Crick and Watson made this ground-breaking discovery at the Cavendish Laboratory in Cambridge. Moreover, Sir John Sulston, winner of last year's Nobel Prize, is also a Cambridge scientist.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jeanette Walker, Business Development Director at ERBI

Jeanette Walker is a graduate in Law and French from the University of Kent. She subsequently gained a Diploma in European Export Marketing from the University of Louvain in Belgium. She has worked in a variety of international business development roles, most recently as Head of New Business for Invest East of England, the regional inward investment agency.

In her current role at ERBI Jeanette also runs a wide range of programmes and events aimed at supporting and growing the biotech cluster in the East of England.

spacer
Jeanette Walker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement